Biosketch

Vincent Goffin is a prominent figure in the field of molecular endocrinology. He completed his education at the University of Liège (Belgium) in 1993 and embarked on a successful research career. After his doctoral studies, he pursued post-doctoral training at Inserm U344 in Paris, where he gained invaluable experience with a Marie-Curie fellowship.

In 1996, he joined Inserm as a tenure researcher and has been leading his research lab since 2006. His work has focused on the prolactin (PRL) and growth hormone (GH) protein family, with significant contributions in onco-endocrinology including the identification of the first gain-of-function PRL receptor genetic variants and the development of PRL receptor inhibitors.

Vincent Goffin's impact extends to his role as the founder of the FASEB Science Research Conference "The GH/PRL Family in Biology & Diseases." He's also served as consultant for companies developing PRL/GH-related compounds and held editorial positions in peer-reviewed journals in onco-endocrinology.

His recent research has shed light on prostate pathophysiology, particularly the discovery of castration-tolerant "Club-like" progenitor cells with implications for benign prostatic hyperplasia and prostate cancer relapse. Vincent Goffin's career has significantly advanced our understanding of molecular endocrinology, making him a leading figure in the field.